Synopsys, Inc. — Form 10-Q Summary
Reporting period: Fiscal third quarter and first nine months of fiscal 2023. The cover identifies the quarter ended July 31, 2023, while the MD&A says fiscal-period results ended July 29, 2023; verify the applicable reporting dates. Comparisons below are year over year. Amounts are in U.S. dollars.
Business context
Synopsys sells electronic design automation (EDA) products and services, semiconductor intellectual property (IP), and software security and quality tools. Fiscal 2023 reporting separates the business into Design Automation, Design IP, and Software Integrity.
Key financial results
| Metric | Q3 FY2023 | Q3 FY2022 | Nine months FY2023 | Nine months FY2022 |
|---|---|---|---|---|
| Revenue | $1,487.3m (+19%) | $1,247.8m | $4,243.5m (+12%) | $3,797.3m |
| Gross margin | $1,179.8m; 79.3% | $976.6m; 78.3% | $3,353.6m; 79.0% | $3,016.3m; 79.4% |
| Operating income | $295.5m (+26%) | $233.9m | $838.7m (-11%) | $944.7m |
| Net income attributable to Synopsys | $336.3m | $222.6m | $880.7m | $831.1m |
| Diluted EPS | $2.17 | $1.43 | $5.68 | $5.31 |
| Operating cash flow | Not presented separately | Not presented separately | $1,377.2m | $1,345.4m |
Q3 operating margin was 19.9%, up from 18.8%. Nine-month operating income fell despite revenue growth, reflecting higher operating expenses, including restructuring and stock-based compensation, and a less favorable deferred-compensation-plan result. Nine-month net income increased; the filing reports an unusually low 2.3% effective tax rate, including a $23.8m net benefit related to the conclusion of Hungary tax litigation.
Q3 revenue growth was led by Design Automation (+23% to $1,004.2m); Design IP rose 12% to $350.2m and Software Integrity rose 12% to $132.9m. For the first nine months, Design Automation grew 16%, Software Integrity 16%, and Design IP 1%. Time-based product revenue rose 22% in Q3, while upfront product revenue rose 11%.
Cash, debt and capital allocation
- Cash, cash equivalents and short-term investments totaled $1,834.6m at July 31, 2023, up from $1,565.5m at October 31, 2022. Cash and short-term investments exceeded current liabilities of $2,730.0m only when deferred revenue and other operating liabilities are considered in context; the filing does not present a conventional adjusted liquidity measure.
- Cash provided by operations was $1,377.2m for nine months; investing used $181.6m and financing used $942.6m. The financing outflow included $860.7m of treasury-stock purchases.
- Debt was $18.2m, with no revolver borrowings. The revolving facility is $850m, matures in December 2027, and Synopsys reported compliance with its leverage covenant.
- The company repurchased $860.7m of stock in the first nine months; $494.3m remained authorized at July 31. The May 2023 accelerated repurchase was $300m, with its remaining $45m settled in August.
- Deferred revenue was $1,939.2m, down from $2,065.3m at October 31, 2022. Contracted unsatisfied or partially unsatisfied performance obligations were approximately $7.1bn, including $1.4bn of non-cancellable FSA commitments; about 42% excluding FSA was expected to be recognized within 12 months.
Material changes, outlook and risks
- Q3 restructuring charges were $33.4m; total charges under the fiscal 2023 plan were $78.4m, and the plan was substantially completed. Remaining restructuring liabilities were $29.0m at period end.
- Management said it had not experienced a material adverse impact from macroeconomic conditions to date, but described continued customer scrutiny and, in some Software Integrity cases, shorter-term contracts. It cited inflation, interest rates, possible downturns, supply-chain issues, foreign exchange, geopolitical tensions and U.S.-China trade controls as uncertainties.
- Management stated existing liquidity should meet cash needs and the capital-return program over the next 12 months and beyond. The filing provides no specific revenue or earnings guidance in the supplied text.
- Synopsys said current export controls were not expected to have a material business impact, but future regulatory changes could affect sales and international customer deployments. China exposure and geopolitical developments remain risks.
- Bell Semiconductor patent actions name customers and other EDA vendors, not Synopsys. Some customers have sought defense or indemnity; Synopsys is defending some customers. Declaratory-judgment actions were set for trial in January 2024.
- Two office buildings with a carrying value of approximately $9.5m were classified as held for sale. The Hungary tax litigation concluded in Synopsys’s favor, and the tax authority refunded taxes, penalties and interest.
Important facts for investors to verify
- Confirm the period-end date and compare reported results with the company’s fiscal calendar; the filing text uses July 31 on the cover but July 29 in the MD&A.
- Assess the sustainability of growth by segment, especially Design IP’s weak nine-month growth and Software Integrity’s noted customer purchasing caution.
- Separate recurring operating performance from the Hungary tax benefit and volatile deferred-compensation-plan gains or losses when evaluating earnings.
- Review the timing and conversion of deferred revenue and performance obligations into revenue, including the FSA commitments and upfront product variability.
- Monitor restructuring cash payments, ongoing buybacks, cash tax payments, export-control developments, and the Bell Semiconductor proceedings and potential customer indemnification exposure.